Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis

Patients with severe uncontrolled asthma still experience acute asthma symptoms and exacerbations, particularly those with non-eosinophilic inflammation who take the maximum amount of standard drug therapy. Tezepelumab, a human monoclonal antibody, can improve lung function and enhance control of as...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaban Abdelgalil, Mahmoud, Ahmed Elrashedy, Asmaa, Awad, Ahmed K., Reda Gad, Eman, Ali, Mahmoud M., Abdelmoez Farahat, Ramadan, Hassan Shawki, Bassant, Abd-ElGawad, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719466/
https://www.ncbi.nlm.nih.gov/pubmed/36463281
http://dx.doi.org/10.1038/s41598-022-24763-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719466/
https://www.ncbi.nlm.nih.gov/pubmed/36463281
http://dx.doi.org/10.1038/s41598-022-24763-9

Ejemplares similares